To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MRPS31TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
349 supporting clones for gene MRPS31 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DW443736 Liver .a 1 to 214 16 to 229   tiling clone,   214/229
(93 %)
6 diff
(97.4 %id)
BF218403 brain, glioblastoma .a 4 to 660 1 to 653       653/872
(74 %)
31 diff
(96.5 %id)
BF213065 bone marrow, from chronic myelogenous leukemia .a 6 to 693 35 to 712       678/909
(74 %)
49 diff
(94.7 %id)
BG722006 testis .a 6 to 821 1 to 820       820/847
(96 %)
20 diff
(97.7 %id)
BQ278244 mixed (pool of 40 RNAs) .a 8 to 668 1 to 667       667/784
(85 %)
16 diff
(98.0 %id)
BG531895 embryonal carcinoma, testis .a 9 to 688 1 to 682       682/907
(75 %)
29 diff
(96.9 %id)
BG614401 embryonal carcinoma, testis .a 9 to 825 1 to 834       832/859
(96 %)
42 diff
(95.2 %id)
AV712217   .a 10 to 371 1 to 362       362/372
(97 %)
2 diff
(99.5 %id)
FN064469 breast carcinoma .a 10 to 64 55 to 1     Submitted on the opposite strand 55/56
(98 %)
0 diff
(100 %id)
NM_005830.3   .a 10 to 1353 1 to 1344 exact RefSeq,   1344/1344
(100 %)
4 diff
(99.8 %id)
DN917881   .a 11 to 651 1 to 639       639/640
(99 %)
6 diff
(99.1 %id)
BF674514 Prostate .a 11 to 678 1 to 662       662/687
(96 %)
27 diff
(96.1 %id)
BG779317 adenocarcinoma, Prostate .a 11 to 696 1 to 685       685/766
(89 %)
15 diff
(98.1 %id)
BG432192 Kidney .a 12 to 683 1 to 683       683/797
(85 %)
31 diff
(96.2 %id)
BG428173 Kidney .a 12 to 773 1 to 760       760/760
(100 %)
12 diff
(98.5 %id)
DW438502 Liver .a 13 to 237 18 to 242       225/245
(91 %)
1 diff
(99.6 %id)
BG430297 Kidney .a 13 to 825 1 to 827       827/828
(99 %)
59 diff
(92.9 %id)
BG944665 blood .a 14 to 316 1 to 303       303/303
(100 %)
3 diff
(99.1 %id)
DA996215 synovial membrane tissue from rheumatioidarthritis .a 15 to 577 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BF694981 muscle (skeletal) .a 16 to 481 1 to 470       470/470
(100 %)
10 diff
(97.9 %id)
BF208768 bladder, carcinoma, cell line .a 18 to 517 1 to 516       516/516
(100 %)
39 diff
(92.5 %id)
BG426457 Kidney .a 18 to 782 1 to 775       773/982
(78 %)
37 diff
(96.3 %id)
TI_44349082   .a 18 to 612 114 to 709       596/709
(84 %)
9 diff
(98.8 %id)
BI560846 testis .a 22 to 612 1 to 592       592/592
(100 %)
4 diff
(99.4 %id)
BG531412 embryonal carcinoma, testis .a 24 to 683 1 to 665       665/801
(83 %)
17 diff
(97.9 %id)
BF241390 bone marrow, from acute myelogenous leukemia .a 25 to 524 1 to 497       497/744
(66 %)
25 diff
(96.7 %id)
BF247049 brain, glioblastoma .a 27 to 685 1 to 652       652/861
(75 %)
37 diff
(95.8 %id)
BU568792 testis .a 27 to 683 1 to 659       659/838
(78 %)
14 diff
(98.4 %id)
CB962714 Blood vessels - aorta, basilar and artery .a 28 to 488 1 to 461       461/512
(90 %)
3 diff
(99.5 %id)
BF242347 bone marrow, from acute myelogenous leukemia .a 29 to 580 1 to 561       561/810
(69 %)
28 diff
(96.6 %id)
BG614293 embryonal carcinoma, testis .a 29 to 824 1 to 795       795/815
(97 %)
21 diff
(97.5 %id)
BG612579 embryonal carcinoma, testis .a 29 to 647 1 to 622       622/739
(84 %)
22 diff
(97.1 %id)
BG613008 embryonal carcinoma, testis .a 29 to 747 1 to 726       726/726
(100 %)
17 diff
(97.7 %id)
BG614815 embryonal carcinoma, testis .a 29 to 825 1 to 806       806/865
(93 %)
16 diff
(98.2 %id)
BG614385 embryonal carcinoma, testis .a 29 to 683 1 to 665       665/996
(66 %)
17 diff
(98.3 %id)
BG615614 embryonal carcinoma, testis .a 29 to 825 1 to 802       802/864
(92 %)
17 diff
(98.1 %id)
BG615812 embryonal carcinoma, testis .a 29 to 845 1 to 817       819/817
(100 %)
15 diff
(98.2 %id)
BG615821 embryonal carcinoma, testis .a 29 to 683 1 to 664       664/1029
(64 %)
15 diff
(98.6 %id)
BG616392 embryonal carcinoma, testis .a 29 to 750 1 to 726       726/726
(100 %)
8 diff
(98.9 %id)
BG616345 embryonal carcinoma, testis .a 29 to 515 1 to 487       487/487
(100 %)
1 diff
(99.8 %id)
BG615490 embryonal carcinoma, testis .a 29 to 748 1 to 716       716/716
(100 %)
11 diff
(98.5 %id)
BE961089 melanotic melanoma, high MDR, skin .a 30 to 689 1 to 667       667/836
(79 %)
31 diff
(96.3 %id)
BF240573 bone marrow, from acute myelogenous leukemia .a 30 to 784 1 to 761       761/762
(99 %)
30 diff
(96.1 %id)
BF210558 bone marrow, from chronic myelogenous leukemia .a 30 to 692 1 to 655       655/796
(82 %)
43 diff
(94.6 %id)
BF573072 melanotic melanoma, high MDR, skin .a 30 to 569 1 to 547       547/803
(68 %)
27 diff
(96.7 %id)
BG534818 lung .a 30 to 821 1 to 800       798/866
(92 %)
22 diff
(97.5 %id)
BG493842 lung, mucoepidermoid carcinoma .a 30 to 749 1 to 719       719/719
(100 %)
3 diff
(99.6 %id)
BG530512 embryonal carcinoma, testis .a 30 to 834 1 to 816       816/817
(99 %)
27 diff
(96.7 %id)
BG530521 embryonal carcinoma, testis .a 30 to 734 1 to 707       707/710
(99 %)
8 diff
(98.9 %id)
BG611978 adenocarcinoma, Prostate .a 30 to 749 1 to 724       724/724
(100 %)
14 diff
(98.1 %id)
FN069165 breast carcinoma .a 31 to 118 87 to 1     Submitted on the opposite strand 87/88
(98 %)
1 diff
(98.9 %id)
BI551873 brain, hippocampus .a 31 to 709 1 to 678       678/678
(100 %)
6 diff
(99.2 %id)
BP372520 umbilical cord .a 31 to 611 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA555458   .a 32 to 581 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
BP873452 embryonal kidney .a 32 to 359 1 to 328       328/328
(100 %)
0 diff
(100 %id)
TI_44169812   .a 32 to 709 83 to 759       677/759
(89 %)
8 diff
(99.0 %id)
AV762264 bone marrow .a 32 to 422 1 to 391       391/411
(95 %)
1 diff
(99.8 %id)
DB240633 trachea .a 32 to 626 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
BE568365 bladder, carcinoma, cell line .a 34 to 687 1 to 640       640/887
(72 %)
28 diff
(96.9 %id)
BG944271 blood .a 38 to 391 1 to 354       354/354
(100 %)
1 diff
(99.8 %id)
BG532793 embryonal carcinoma, testis .a 39 to 753 1 to 713       713/713
(100 %)
10 diff
(98.6 %id)
BC022045 Testis, embryonal carcinoma .a 42 to 1341 1 to 1300 T80I T132A available from MGC, AAA   1300/1300
(100 %)
8 diff
(99.4 %id)
BU071451 insulinoma, Pancreas .a 42 to 666 7 to 633       627/633
(99 %)
13 diff
(98.0 %id)
BU789907 insulinoma, Pancreas .a 42 to 456 7 to 423       417/423
(98 %)
8 diff
(98.2 %id)
CX762442 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 44 to 791 1 to 739     Submitted on the opposite strand 739/844
(87 %)
12 diff
(98.6 %id)
BG505748 embryonal carcinoma, testis .a 45 to 683 1 to 639       639/780
(81 %)
6 diff
(99.3 %id)
BF689670 melanotic melanoma, high MDR (cell line), skin .a 45 to 396 1 to 351   fully sequenced,   351/351
(100 %)
1 diff
(99.8 %id)
BG615880 embryonal carcinoma, testis .a 45 to 825 1 to 787       787/791
(99 %)
16 diff
(98.0 %id)
EL946202 eyeball .a 49 to 644 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
BF028302 bladder, carcinoma, cell line .a 49 to 683 1 to 645       645/786
(82 %)
25 diff
(96.9 %id)
CD511192 Blood vessels - aorta, basilar and artery .a 49 to 611 1 to 572       572/697
(82 %)
17 diff
(97.6 %id)
CF597459 ovary .a 49 to 685 1 to 645       643/928
(69 %)
21 diff
(97.8 %id)
BE960672 melanotic melanoma, high MDR, skin .a 50 to 524 1 to 475       475/724
(65 %)
10 diff
(98.7 %id)
BU854042 testis .a 50 to 685 1 to 643       643/692
(92 %)
23 diff
(96.7 %id)
CD103574 Pooled-Skin .a 50 to 778 1 to 734       734/735
(99 %)
14 diff
(98.1 %id)
BG033166 breast, mammary adenocarcinoma, cell line .a 51 to 817 1 to 776       772/863
(89 %)
25 diff
(97.2 %id)
BG493477 lung, mucoepidermoid carcinoma .a 51 to 571 1 to 521       521/521
(100 %)
5 diff
(99.1 %id)
BG538308 lung .a 51 to 679 1 to 633       633/932
(67 %)
20 diff
(97.9 %id)
BG613023 embryonal carcinoma, testis .a 51 to 805 1 to 759       759/759
(100 %)
18 diff
(97.7 %id)
AK315248 heart .a 52 to 1272 1 to 1221 exact     1221/1221
(100 %)
0 diff
(100 %id)
BE565977 bladder, carcinoma, cell line .a 52 to 680 1 to 614       614/641
(95 %)
27 diff
(95.8 %id)
BF697498 brain, primitive neuroectoderm .a 52 to 724 1 to 673       673/673
(100 %)
17 diff
(97.5 %id)
BM753808 stomach .a 52 to 524 1 to 474       474/480
(98 %)
4 diff
(99.2 %id)
CR610235 Neuroblastoma Cot 25-normalized .a 53 to 1312 1 to 1260 exact     1260/1260
(100 %)
0 diff
(100 %id)
AL525614 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 53 to 855 1 to 805   fully sequenced,   805/805
(100 %)
2 diff
(99.8 %id)
DA566704 heart .a 53 to 592 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BG025463 lymph, lymphoma, cell line .a 53 to 821 1 to 774       774/795
(97 %)
14 diff
(98.3 %id)
DR762692 embryonic stem .a 53 to 915 13 to 875       863/875
(98 %)
10 diff
(98.9 %id)
DA900154 skeletal muscle .a 53 to 623 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BF210656 bone marrow, from chronic myelogenous leukemia .a 55 to 589 4 to 546       543/822
(66 %)
32 diff
(96.2 %id)
BF245944 brain, glioblastoma .a 57 to 683 1 to 623       623/629
(99 %)
20 diff
(96.9 %id)
CN292210 embryonic stem cells, DMSO-treated H9 cellline .a 58 to 638 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DW422089 Liver .a 58 to 335 18 to 295       278/295
(94 %)
6 diff
(98.0 %id)
BG563998 Liver .a 58 to 719 1 to 661       661/661
(100 %)
8 diff
(98.8 %id)
BE565418 bladder, carcinoma, cell line .a 59 to 592 1 to 539       539/546
(98 %)
13 diff
(97.7 %id)
CX869400 embryonic stem .a 59 to 714 1 to 656   fully sequenced,   656/656
(100 %)
0 diff
(100 %id)
AA307686 colon .a 60 to 614 1 to 555       555/555
(100 %)
0 diff
(100 %id)
TI_154103328   .a 60 to 823 836 to 73   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 764/1086
(70 %)
3 diff
(99.8 %id)
BC010159 Lymph, Burkitt lymphoma .a 64 to 823 1 to 760   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 760/769
(98 %)
2 diff
(99.8 %id)
BE562073 Burkitt lymphoma, lymph .a 64 to 675 32 to 650   available from MGC,   621/652
(95 %)
20 diff
(97.0 %id)
AA317212 retina .a 66 to 354 1 to 289       289/289
(100 %)
1 diff
(99.7 %id)
BE559706 Burkitt lymphoma, lymph .a 67 to 811 52 to 797       746/797
(93 %)
9 diff
(98.9 %id)
TI_57199513   .a 69 to 817 74 to 832       756/954
(79 %)
19 diff
(98.1 %id)
BM722545 eye, fetal eye .a 69 to 736 1 to 668   fully sequenced,   668/668
(100 %)
0 diff
(100 %id)
AI878840.
matches multiple genes
brain, frontal lobe .a 70 to 626 1 to 557     also hits gene XKR4 557/558
(99 %)
1 diff
(99.9 %id)
AA393447   .a 71 to 374 1 to 303   fully sequenced,   303/303
(100 %)
0 diff
(100 %id)
BI819120 pooled brain, lung, testis .a 71 to 817 1 to 757       754/879
(85 %)
14 diff
(98.5 %id)
CX757030 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 71 to 828 1 to 751     Submitted on the opposite strand 751/760
(98 %)
12 diff
(98.5 %id)
TI_57200579   .a 71 to 906 65 to 909   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 839/910
(92 %)
30 diff
(96.8 %id)
R08056 liver and spleen .a 72 to 311 1 to 248   fully sequenced,   248/248
(100 %)
5 diff
(98.0 %id)
AA203716 liver and spleen .a 72 to 683 1 to 607       607/971
(62 %)
22 diff
(97.8 %id)
BI821428 pooled brain, lung, testis .a 72 to 821 1 to 752       750/845
(88 %)
4 diff
(99.6 %id)
AA377022 small intestine .a 73 to 337 1 to 265       265/265
(100 %)
0 diff
(100 %id)
CN292213 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 73 to 580 1 to 508       508/508
(100 %)
0 diff
(100 %id)
W78768 liver and spleen .a 73 to 394 1 to 324   fully sequenced,   324/324
(100 %)
4 diff
(98.8 %id)
CF142105 CNCAP(3)T-225 cell line, Prostate .a 73 to 548 8 to 483       476/483
(98 %)
7 diff
(98.6 %id)
CF145552 CNCAP(3)T-225 cell line, Prostate .a 73 to 743 8 to 678       671/678
(98 %)
6 diff
(99.2 %id)
BM796061 Ascites, stomach .a 73 to 544 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
TI_154172967   .a 73 to 682 89 to 701       613/1372
(44 %)
13 diff
(99.1 %id)
TI_154177793   .a 73 to 881 77 to 875       801/939
(85 %)
17 diff
(98.2 %id)
CX759077 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 74 to 779 1 to 706     Submitted on the opposite strand 706/706
(100 %)
0 diff
(100 %id)
CA777160 Pancreas, Purified pancreatic islet .a 76 to 545 10 to 479   fully sequenced,   470/479
(98 %)
6 diff
(98.8 %id)
AA312974 colon .a 77 to 489 1 to 414       414/414
(100 %)
1 diff
(99.8 %id)
DN997986 breast cancer, Mammary gland (cancer tissue) .a 77 to 683 1 to 608       608/614
(99 %)
8 diff
(98.7 %id)
AW950148   .a 78 to 623 1 to 546       546/582
(93 %)
11 diff
(98.2 %id)
AW951658   .a 78 to 518 1 to 444       444/446
(99 %)
9 diff
(98.0 %id)
EL952653 eyeball .a 78 to 514 31 to 467       437/467
(93 %)
6 diff
(98.8 %id)
CR614348 neuroblastoma .a 79 to 1326 1 to 1248 exact tiling clone,   1248/1248
(100 %)
0 diff
(100 %id)
AL518732 brain, neuroblastoma, neuroblastoma cells .a 79 to 929 1 to 849   fully sequenced,   849/849
(100 %)
7 diff
(99.2 %id)
Z68747 forearm skin .a 80 to 1281 1 to 1202 D279N     1202/1202
(100 %)
1 diff
(100.0 %id)
TI_1948126527   .a 81 to 607 130 to 658       529/1307
(40 %)
32 diff
(97.6 %id)
CV029060 mixed .a 85 to 737 1 to 652       652/652
(100 %)
5 diff
(99.3 %id)
TI_1948126085   .a 85 to 685 126 to 727       602/1429
(42 %)
20 diff
(98.7 %id)
TI_1948126077   .a 85 to 855 139 to 910   fully sequenced,   772/874
(88 %)
8 diff
(99.1 %id)
TI_1948126229   .a 85 to 766 162 to 851       687/1293
(53 %)
49 diff
(96.3 %id)
TI_1948126384   .a 85 to 767 127 to 811   fully sequenced,   685/773
(88 %)
16 diff
(98.0 %id)
TI_1948126523   .a 85 to 639 129 to 684   fully sequenced,   556/684
(81 %)
10 diff
(98.6 %id)
F12626 brain, total brain .a 95 to 398 1 to 303       303/303
(100 %)
2 diff
(99.4 %id)
CN292209 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 95 to 881 1 to 789       789/789
(100 %)
3 diff
(99.7 %id)
FN098332 breast carcinoma .a 95 to 204 110 to 1     Submitted on the opposite strand 110/110
(100 %)
4 diff
(96.4 %id)
BE279600 choriocarcinoma, placenta .a 99 to 662 1 to 564       564/565
(99 %)
1 diff
(99.9 %id)
CX754188 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 114 to 872 1 to 755     Submitted on the opposite strand 755/755
(100 %)
11 diff
(98.6 %id)
BM013606 breast, mammary adenocarcinoma, cell line .a 119 to 830 1 to 710       710/713
(99 %)
9 diff
(98.8 %id)
TI_59391509   .a 119 to 830 145 to 854       710/773
(91 %)
9 diff
(98.9 %id)
T74162 whole brain .a 125 to 366 1 to 239       239/239
(100 %)
5 diff
(98.0 %id)
EL954140 eyeball .a 126 to 580 1 to 455       455/455
(100 %)
2 diff
(99.6 %id)
BU607618 Human Lung Epithelial cells, lung .a 126 to 823 708 to 11   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 698/708
(98 %)
0 diff
(100 %id)
BY796274 eye .a 130 to 683 1 to 554       554/555
(99 %)
0 diff
(100 %id)
CK724998 Chondrosarcoma, Left Pubic Bone .a 141 to 823 694 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 683/694
(98 %)
2 diff
(99.8 %id)
BU626224 cell lines, Enchondroma .a 150 to 823 688 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 677/688
(98 %)
7 diff
(99.0 %id)
AI937794 anaplastic oligodendroglioma, brain .a 163 to 824 663 to 1       663/663
(100 %)
33 diff
(95.1 %id)
DB069950 testis .a 202 to 733 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
AW515905 lymph node, lymphoma, follicular mixed small and largecell .a 225 to 814 590 to 1       590/622
(94 %)
28 diff
(95.5 %id)
CN292212 embryonic stem cells, cell lines H1, H7, andH9 .a 233 to 606 7 to 380       377/380
(99 %)
6 diff
(98.5 %id)
BG614457 embryonal carcinoma, testis .a 239 to 803 262 to 832       571/833
(68 %)
28 diff
(96.7 %id)
BU658138 blood .a 253 to 569 1 to 317       317/317
(100 %)
0 diff
(100 %id)
FN098679 breast carcinoma .a 255 to 326 71 to 1     Submitted on the opposite strand 71/72
(98 %)
1 diff
(98.7 %id)
BX106322 liver and spleen .a 259 to 1036 1 to 778       778/782
(99 %)
2 diff
(99.8 %id)
TI_157611657   .a 262 to 823 646 to 83   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 564/646
(87 %)
38 diff
(94.2 %id)
FN072042 breast carcinoma .a 268 to 364 97 to 1     Submitted on the opposite strand 97/98
(98 %)
0 diff
(100 %id)
R08007 liver and spleen .a 281 to 810 546 to 9   fully sequenced,   538/546
(98 %)
19 diff
(96.6 %id)
AA777532 liver and spleen .a 286 to 815 530 to 1       530/530
(100 %)
6 diff
(98.9 %id)
AJ711935 heart .a 287 to 815 531 to 3     Submitted on the opposite strand 529/531
(99 %)
0 diff
(100 %id)
TI_154189348   .a 303 to 1261 50 to 997       948/1027
(92 %)
15 diff
(98.6 %id)
CF126369 Chondrosarcoma Lung Metastasis cell lines, lung .a 304 to 1097 1 to 794       794/794
(100 %)
0 diff
(100 %id)
BG111140 Bone, osteosarcoma, cell line .a 307 to 733 1 to 438       438/742
(59 %)
16 diff
(97.9 %id)
AA398743   .a 344 to 819 477 to 1   fully sequenced,   477/477
(100 %)
1 diff
(99.8 %id)
AI033060 liver and spleen .a 361 to 817 456 to 1       456/459
(99 %)
3 diff
(99.4 %id)
W81120 liver and spleen .a 364 to 816 461 to 1   fully sequenced,   461/461
(100 %)
8 diff
(98.3 %id)
BF690564 melanotic melanoma, high MDR (cell line), skin .a 366 to 793 438 to 9   fully sequenced,   430/438
(98 %)
0 diff
(100 %id)
AW205419   .a 379 to 823 455 to 11   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 445/466
(95 %)
6 diff
(98.8 %id)
AW779114 pooled .a 396 to 817 434 to 1       434/466
(93 %)
25 diff
(94.7 %id)
AA969817 2 pooled tumors (clear cell type), Kidney .a 404 to 816 414 to 1       414/417
(99 %)
3 diff
(99.3 %id)
BE788707 large cell carcinoma, lung .a 409 to 1209 1 to 812       814/1059
(76 %)
46 diff
(95.7 %id)
FN099658 breast carcinoma .a 424 to 522 1 to 93       93/105
(88 %)
5 diff
(95.3 %id)
TI_149309570   .a 430 to 1237 880 to 79   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 802/1025
(78 %)
7 diff
(99.4 %id)
TI_149301880   .a 444 to 1340 970 to 81   AAA   890/975
(91 %)
16 diff
(98.4 %id)
AA234689 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 453 to 737 1 to 289       286/289
(98 %)
18 diff
(93.8 %id)
AA602060   .a 456 to 821 366 to 1       366/367
(99 %)
0 diff
(100 %id)
CK301093 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 475 to 823 360 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 349/369
(94 %)
0 diff
(100 %id)
TI_151808695   .a 475 to 823 79 to 427   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 349/1033
(33 %)
1 diff
(100.0 %id)
BU687955 lung .a 478 to 1235 767 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 756/767
(98 %)
3 diff
(99.7 %id)
TI_154109409   .a 485 to 1344 944 to 89   AAA   856/986
(86 %)
9 diff
(99.1 %id)
BG943051 blood .a 508 to 998 1 to 491       491/491
(100 %)
0 diff
(100 %id)
AJ711560 heart .a 511 to 995 1 to 485       485/485
(100 %)
0 diff
(100 %id)
CA776875 Pancreas, Purified pancreatic islet .a 523 to 815 293 to 1   fully sequenced,   293/293
(100 %)
7 diff
(97.7 %id)
TI_154102534   .a 526 to 1340 886 to 82   AAA   805/811
(99 %)
21 diff
(97.5 %id)
BG614241 embryonal carcinoma, testis .a 544 to 1145 1 to 603       601/603
(99 %)
2 diff
(99.7 %id)
CA415439 Chondrosarcoma Grade II, Left Pelvis .a 594 to 1340 763 to 17   AAA   747/747
(100 %)
1 diff
(99.9 %id)
BU621944 Cell Line, Chondrosarcoma .a 594 to 1340 763 to 17   AAA   747/747
(100 %)
1 diff
(99.9 %id)
CD367997 Alveolar Macrophage, lung .a 605 to 1342 754 to 17   AAA   738/738
(100 %)
1 diff
(99.9 %id)
TI_1948126524   .a 609 to 1271 785 to 113   fully sequenced,   673/785
(85 %)
7 diff
(99.2 %id)
AI741536 pooled .a 611 to 1341 726 to 4       723/760
(95 %)
8 diff
(99.0 %id)
DA800393 brain .a 619 to 1144 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
BM980164 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 620 to 1340 736 to 17   AAA   720/720
(100 %)
1 diff
(99.9 %id)
CA447875 Chondrosarcoma, Left Pelvis .a 620 to 1344 743 to 19   AAA   725/725
(100 %)
0 diff
(100 %id)
CX869327 embryonic stem .a 653 to 1340 713 to 26   fully sequenced, AAA   688/688
(100 %)
1 diff
(99.9 %id)
AW083272 colon, moderately differentiated adenocarcinoma .a 676 to 1340 663 to 1       663/688
(96 %)
11 diff
(98.5 %id)
BU071227 insulinoma, Pancreas .a 676 to 1296 621 to 1       621/621
(100 %)
0 diff
(100 %id)
TI_149276226   .a 676 to 1340 755 to 92   AAA   664/927
(71 %)
22 diff
(97.7 %id)
TI_1948126086   .a 684 to 1277 741 to 135       607/1488
(40 %)
34 diff
(97.8 %id)
BU789584 insulinoma, Pancreas .a 692 to 982 291 to 1       291/292
(99 %)
12 diff
(95.9 %id)
AI762447 pooled .a 697 to 1043 349 to 3       347/349
(99 %)
1 diff
(99.8 %id)
BU789634 insulinoma, Pancreas .a 697 to 1293 601 to 4       598/601
(99 %)
5 diff
(99.2 %id)
CD676563 eye, Trabecular meshwork .a 699 to 1228 1 to 530       530/530
(100 %)
1 diff
(99.9 %id)
N47377 multiple sclerosis lesions .a 702 to 986 1 to 286   fully sequenced,   286/286
(100 %)
5 diff
(98.3 %id)
AA706890 liver and spleen .a 721 to 1338 618 to 1       618/618
(100 %)
6 diff
(99.1 %id)
AI636049 Kidney .a 724 to 1339 616 to 2       615/616
(99 %)
1 diff
(99.9 %id)
BU608889 Human Lung Epithelial cells, lung .a 725 to 1340 632 to 17   AAA   616/616
(100 %)
1 diff
(99.9 %id)
BM679053 eye, fetal eye .a 726 to 1340 632 to 17   fully sequenced, AAA   616/616
(100 %)
1 diff
(99.9 %id)
TI_149276752   .a 732 to 1235 674 to 167       508/892
(56 %)
19 diff
(97.9 %id)
CN479481 Chondrosarcoma, Left Pubic Bone .a 733 to 1340 625 to 17   AAA   609/609
(100 %)
1 diff
(99.9 %id)
TI_1948126385   .a 737 to 1271 689 to 146   fully sequenced,   544/689
(78 %)
16 diff
(97.7 %id)
BE004772 breast_normal .a 738 to 983 1 to 246       246/247
(99 %)
3 diff
(98.8 %id)
BE814988 breast_normal .a 738 to 983 1 to 248       248/249
(99 %)
8 diff
(96.8 %id)
AI077473 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 754 to 1347 593 to 1       593/593
(100 %)
1 diff
(99.9 %id)
AW629020 pooled .a 760 to 1341 583 to 2       582/583
(99 %)
1 diff
(99.9 %id)
AA886331 2 pooled tumors (clear cell type), Kidney .a 763 to 1341 581 to 4       578/581
(99 %)
11 diff
(98.2 %id)
DN917882   .a 775 to 1335 564 to 4       561/564
(99 %)
2 diff
(99.7 %id)
AA742194 germinal center B cell .a 781 to 1340 571 to 13   AAA   559/559
(100 %)
5 diff
(99.2 %id)
AL562530 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 794 to 1312 520 to 1   fully sequenced,   520/520
(100 %)
7 diff
(98.7 %id)
BF111436 pooled .a 799 to 1341 548 to 6       543/548
(99 %)
2 diff
(99.7 %id)
AA947589 pooled .a 805 to 1341 539 to 3       537/539
(99 %)
0 diff
(100 %id)
TI_1948126078   .a 815 to 1271 602 to 145   fully sequenced,   458/602
(76 %)
5 diff
(99.2 %id)
CB159997 Liver .a 818 to 1340 543 to 21   AAA Submitted on the opposite strand 523/523
(100 %)
3 diff
(99.5 %id)
AA449962   .a 823 to 1264 442 to 1       442/445
(99 %)
14 diff
(96.9 %id)
AA757113   .a 825 to 1341 518 to 3       516/518
(99 %)
5 diff
(99.1 %id)
AA947316 2 pooled tumors (clear cell type), Kidney .a 825 to 1341 519 to 4       516/519
(99 %)
8 diff
(98.5 %id)
CB854024 lung, Primary Lung Epithelial Cells .a 825 to 1235 430 to 20       411/430
(95 %)
5 diff
(98.9 %id)
AI700828 Kidney .a 826 to 1348 535 to 7       529/544
(97 %)
9 diff
(98.4 %id)
AI241550 liver and spleen .a 827 to 1341 515 to 1       515/519
(99 %)
11 diff
(97.9 %id)
AI271803 Kidney .a 830 to 1340 508 to 1       508/508
(100 %)
4 diff
(99.3 %id)
AI146291 heart .a 832 to 1340 509 to 1       509/509
(100 %)
1 diff
(99.9 %id)
AI276449 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 847 to 1339 493 to 1       493/493
(100 %)
3 diff
(99.4 %id)
AI127882 uterus .a 851 to 1341 495 to 5       491/496
(98 %)
2 diff
(99.6 %id)
AL518731 brain, neuroblastoma, neuroblastoma cells .a 868 to 1326 459 to 1   fully sequenced,   459/459
(100 %)
2 diff
(99.6 %id)
AI343739 2 pooled tumors (clear cell type), Kidney .a 871 to 1348 483 to 6       478/483
(98 %)
1 diff
(99.8 %id)
AI990044 pooled germ cell tumors .a 880 to 1341 472 to 9       464/472
(98 %)
0 diff
(100 %id)
BM968897 lung, Primary Lung Epithelial Cells .a 880 to 1340 477 to 17   AAA   461/461
(100 %)
0 diff
(100 %id)
N51509 multiple sclerosis lesions .a 885 to 1339 458 to 1       458/458
(100 %)
5 diff
(99.0 %id)
N63081 multiple sclerosis lesions .a 897 to 1340 447 to 1       447/451
(99 %)
6 diff
(98.7 %id)
AI285360 adenocarcinoma, colon .a 897 to 1340 444 to 1       444/521
(85 %)
1 diff
(99.9 %id)
AI354757 lung .a 897 to 1341 444 to 1       444/446
(99 %)
1 diff
(99.8 %id)
AW269531 pooled .a 897 to 1341 446 to 3       444/456
(97 %)
1 diff
(99.8 %id)
BQ012282 placenta .a 897 to 1340 460 to 17   AAA   444/451
(98 %)
0 diff
(100 %id)
AA642584 normal prostate, Prostate .a 898 to 1264 367 to 1       367/370
(99 %)
14 diff
(96.3 %id)
AA904165 carcinoid, lung .a 898 to 1339 443 to 1       443/525
(84 %)
1 diff
(99.9 %id)
AA971808 pooled .a 899 to 1340 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AI689634 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 899 to 1339 446 to 7       440/573
(76 %)
5 diff
(99.2 %id)
AW268841 pooled .a 899 to 1267 370 to 1       370/370
(100 %)
3 diff
(99.2 %id)
BE350161 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 899 to 1330 442 to 10       433/442
(97 %)
8 diff
(98.2 %id)
CK902490 Pancreas, Purified pancreatic islet .a 899 to 1291 394 to 1     Submitted on the opposite strand 394/394
(100 %)
8 diff
(98.0 %id)
AI263845 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 900 to 1340 437 to 1       437/442
(98 %)
10 diff
(97.8 %id)
AA461179   .a 902 to 1264 363 to 1       363/364
(99 %)
6 diff
(98.4 %id)
AI344511 2 pooled tumors (clear cell type), Kidney .a 907 to 1348 447 to 6       442/447
(98 %)
0 diff
(100 %id)
AI540233 pooled .a 907 to 1340 455 to 23   AAA   433/433
(100 %)
10 diff
(97.7 %id)
AI633954 Kidney .a 907 to 968 61 to 1       61/61
(100 %)
1 diff
(98.4 %id)
BI827737 brain, medulla .a 907 to 1340 1 to 434   AAA   434/434
(100 %)
0 diff
(100 %id)
BI827851 brain, medulla .a 907 to 1341 1 to 441       441/749
(58 %)
11 diff
(98.6 %id)
TI_57171965   .a 907 to 1340 71 to 504   AAA   434/504
(86 %)
6 diff
(98.9 %id)
AI800626 pooled .a 910 to 1341 435 to 4       432/435
(99 %)
0 diff
(100 %id)
AI864688 pooled .a 910 to 1341 435 to 4       432/435
(99 %)
1 diff
(99.8 %id)
R51362 whole brain .a 915 to 1341 443 to 7       437/443
(98 %)
10 diff
(97.8 %id)
AI753599 bone marrow stroma .a 917 to 1338 448 to 27   AAA   422/422
(100 %)
0 diff
(100 %id)
AI343737 2 pooled tumors (clear cell type), Kidney .a 925 to 1348 428 to 6       423/428
(98 %)
4 diff
(99.1 %id)
AA492472 colon .a 928 to 1341 415 to 1       415/415
(100 %)
2 diff
(99.6 %id)
AI749736 colon .a 929 to 1338 410 to 1       410/410
(100 %)
0 diff
(100 %id)
BF055245 pooled .a 929 to 1339 411 to 1       411/411
(100 %)
0 diff
(100 %id)
BF476287 Prostate .a 934 to 1220 289 to 3       287/289
(99 %)
4 diff
(98.7 %id)
AA812606   .a 941 to 1341 401 to 3       399/402
(99 %)
12 diff
(97.1 %id)
AI828646 Prostate .a 950 to 1340 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AA011238 heart .a 953 to 1324 1 to 376   fully sequenced,   376/376
(100 %)
5 diff
(98.7 %id)
N56992 multiple sclerosis lesions .a 956 to 1339 385 to 1   fully sequenced,   385/385
(100 %)
1 diff
(99.8 %id)
AI300290 placenta .a 970 to 1341 381 to 9       373/381
(97 %)
1 diff
(99.8 %id)
TI_149274811   .a 972 to 1507 619 to 84   AAA   536/989
(54 %)
0 diff
(100 %id)
BU676330 lung, Primary Lung Epithelial Cells .a 972 to 1507 551 to 16   AAA   536/544
(98 %)
0 diff
(100 %id)
BQ012570 placenta .a 980 to 1340 378 to 17   AAA   362/362
(100 %)
1 diff
(99.8 %id)
C02127   .a 987 to 1222 1 to 236       236/236
(100 %)
0 diff
(100 %id)
AI636212 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 989 to 1340 352 to 1       352/352
(100 %)
0 diff
(100 %id)
H95451 placenta .a 1006 to 1327 338 to 14       325/338
(96 %)
1 diff
(99.8 %id)
AA010410 heart .a 1012 to 1341 330 to 1   fully sequenced,   330/330
(100 %)
0 diff
(100 %id)
BG200390   .a 1035 to 1337 8 to 311   AAA   304/311
(97 %)
6 diff
(98.1 %id)
BG183172   .a 1037 to 1340 1 to 300   AAA   300/302
(99 %)
7 diff
(97.7 %id)
BG185373   .a 1037 to 1340 1 to 303   AAA   303/304
(99 %)
6 diff
(98.1 %id)
BG207138   .a 1037 to 1336 2 to 308   AAA   307/308
(99 %)
10 diff
(96.8 %id)
BG208181   .a 1037 to 1334 1 to 306   AAA   306/306
(100 %)
12 diff
(96.1 %id)
BG208588   .a 1037 to 1340 1 to 304   AAA   304/305
(99 %)
13 diff
(95.8 %id)
BG210797   .a 1037 to 1339 1 to 305   AAA   305/305
(100 %)
10 diff
(96.8 %id)
BG211300   .a 1037 to 1340 1 to 298   AAA   298/300
(99 %)
8 diff
(97.4 %id)
BG221074   .a 1037 to 1340 1 to 304   AAA   304/304
(100 %)
2 diff
(99.4 %id)
BG185900   .a 1039 to 1340 1 to 301   AAA   301/301
(100 %)
3 diff
(99.1 %id)
BG208081   .a 1039 to 1340 1 to 302   AAA   302/302
(100 %)
4 diff
(98.7 %id)
BG219214   .a 1039 to 1340 1 to 302   AAA   302/302
(100 %)
2 diff
(99.4 %id)
BG200389   .a 1040 to 1340 1 to 298   AAA   298/298
(100 %)
5 diff
(98.4 %id)
BG214493   .a 1040 to 1340 1 to 300   AAA   300/300
(100 %)
6 diff
(98.0 %id)
N50420 multiple sclerosis lesions .a 1041 to 1340 299 to 1       299/304
(98 %)
1 diff
(99.7 %id)
BE044368 pooled .a 1042 to 1341 300 to 1       300/459
(65 %)
1 diff
(99.8 %id)
BG213872   .a 1043 to 1284 34 to 275       242/275
(88 %)
8 diff
(97.1 %id)
BG197644   .a 1057 to 1340 28 to 309   AAA   282/309
(91 %)
7 diff
(97.8 %id)
BG194732   .a 1064 to 1341 2 to 278       277/289
(95 %)
7 diff
(97.6 %id)
G43243   .a 1081 to 1298 220 to 1     Submitted on the opposite strand 220/220
(100 %)
2 diff
(99.1 %id)
F10242 brain, total brain .a 1104 to 1340 237 to 1       237/237
(100 %)
0 diff
(100 %id)
BP386368 pancreatic islet .a 1109 to 1341 1 to 234     Submitted on the opposite strand 234/237
(98 %)
4 diff
(98.4 %id)
AW194661 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 1120 to 1267 148 to 1       148/181
(81 %)
18 diff
(90.1 %id)
AI684682 pooled .a 1183 to 1732 560 to 12   tiling clone,   549/560
(98 %)
0 diff
(100 %id)
AA358244 lung .a 1191 to 1340 150 to 1       150/150
(100 %)
0 diff
(100 %id)
FN148849 breast carcinoma .a 1253 to 1338 1 to 87       87/91
(95 %)
5 diff
(94.6 %id)
BG943568 blood .b 1 to 592 3 to 594   tiling clone,   594/594
(100 %)
1 diff
(99.9 %id)
AA194674 muscle, skeletal muscle .b 149 to 305 1 to 157       157/157
(100 %)
1 diff
(99.4 %id)
AA194618 muscle, skeletal muscle .b 942 to 1206 265 to 1   tiling clone,   265/265
(100 %)
0 diff
(100 %id)
BF667187 brain, primitive neuroectoderm .c 1 to 628 1 to 623   tiling clone,   623/769
(81 %)
12 diff
(98.5 %id)
BQ006817 Chondrosarcoma, Left Pelvis .c 451 to 1143 710 to 17   tiling clone, AAA   694/697
(99 %)
1 diff
(99.9 %id)
BU568787 testis .d 1 to 515 1 to 518   tiling clone,   518/850
(60 %)
9 diff
(99.0 %id)
AA004354 liver and spleen .d 95 to 427 1 to 336       336/336
(100 %)
3 diff
(99.2 %id)
BM715872 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 252 to 687 1 to 436   fully sequenced,   436/436
(100 %)
0 diff
(100 %id)
TI_151776900   .d 252 to 802 107 to 654   tiling clone,   548/1278
(42 %)
11 diff
(99.2 %id)
BQ574765 Chondrosarcoma Grade II, Left Pelvis .d 422 to 1098 695 to 19   tiling clone, AAA   677/677
(100 %)
0 diff
(100 %id)
BM674200 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 626 to 1098 489 to 17   fully sequenced, AAA   473/473
(100 %)
0 diff
(100 %id)
AA004355 liver and spleen .d 825 to 1078 257 to 1       257/257
(100 %)
3 diff
(98.9 %id)
BG563180 Liver .e 1 to 586 9 to 594 K150E R151K K152E N153K I154Y ... tiling clone,   592/594
(99 %)
3 diff
(99.5 %id)
W24797 heart .f 1 to 351 1 to 352   tiling clone,   352/472
(74 %)
6 diff
(98.8 %id)
DB112299 thymus .f 849 to 1433 2 to 587   tiling clone, capped   586/586
(100 %)
3 diff
(99.5 %id)
DA832111 placenta .f 859 to 1543 2 to 690   capped   689/751
(91 %)
15 diff
(98.1 %id)
BX437430 thymus .f 936 to 1700 1 to 765       765/802
(95 %)
8 diff
(99.1 %id)
T78211 whole brain .f 945 to 1329 1 to 393       393/440
(89 %)
9 diff
(98.0 %id)
DA568214 whole embryo, mainly head .f 1021 to 1741 2 to 725   tiling clone, capped   724/735
(98 %)
5 diff
(99.4 %id)
BF695303 muscle (skeletal) .f 1282 to 1931 1 to 650   tiling clone,   650/650
(100 %)
17 diff
(97.4 %id)
BX437429 thymus .f 1781 to 2713 934 to 1 exact tiling clone,   934/934
(100 %)
7 diff
(99.3 %id)
AA461355.
matches multiple genes
  .f 1952 to 2540 1 to 589   tiling clone, also hits gene KCTD7andRABGEF1 589/589
(100 %)
4 diff
(99.4 %id)
BQ002789 Chondrosarcoma, Left Pelvis .f 1959 to 2725 777 to 17 exact tiling clone, AAA   761/761
(100 %)
6 diff
(99.3 %id)
CA413980 Chondrosarcoma Grade II, Left Pelvis .f 2017 to 2725 726 to 19 V99G T100D C101L G102W L103P ... AAA   708/708
(100 %)
3 diff
(99.6 %id)
CA390594 eye, RPE/choroid .f 2042 to 2564 1 to 523       523/523
(100 %)
3 diff
(99.5 %id)
DB354699 whole embryo, mainly head .f 2062 to 2613 549 to 1       549/552
(99 %)
8 diff
(98.6 %id)
DB378114 placenta .f 2117 to 2725 604 to 1 L3X T18N S19I P20T S21F ...     604/606
(99 %)
16 diff
(97.4 %id)
W79354 heart .f 2120 to 2429 1 to 310   fully sequenced,   310/310
(100 %)
1 diff
(99.7 %id)
BU072217 Pancreas, Purified pancreatic islet .f 2133 to 2725 1 to 593 D24N AAA   593/593
(100 %)
3 diff
(99.5 %id)
BU076201 Pancreas, Purified pancreatic islet .f 2171 to 2724 554 to 1 D24N P91T     554/554
(100 %)
2 diff
(99.7 %id)
DB343414 thymus .f 2194 to 2732 539 to 1 exact     539/539
(100 %)
0 diff
(100 %id)
AW274392 pooled .f 2198 to 2733 539 to 4 exact tiling clone,   536/539
(99 %)
0 diff
(100 %id)
CK902489 Pancreas, Purified pancreatic islet .f 2199 to 2724 1 to 527 D24N Q48L W49C N62L E63*   Submitted on the opposite strand 527/527
(100 %)
9 diff
(98.3 %id)
W02768 heart .f 2292 to 2726 450 to 1       450/451
(99 %)
17 diff
(96.3 %id)
R37869 whole brain .f 2341 to 2726 405 to 9       397/439
(90 %)
12 diff
(97.3 %id)
W74061 heart .f 2397 to 2725 339 to 1   fully sequenced,   339/339
(100 %)
2 diff
(99.5 %id)
CK819878 Islets of Langerhans, Pancreas .g 1 to 573 1 to 573 exact tiling clone,   573/573
(100 %)
0 diff
(100 %id)
BM142076 Islets of Langerhans, Pancreas .g 17 to 523 1 to 507       507/507
(100 %)
0 diff
(100 %id)
AA358245 lung .h 1 to 286 1 to 287 D59* tiling clone,   285/287
(99 %)
2 diff
(99.4 %id)
AA167172   .i-u 1 to 388 1 to 390 exact tiling clone,   390/390
(100 %)
7 diff
(98.3 %id)
BE079892 breast .i-u 192 to 827 10 to 639       630/686
(91 %)
16 diff
(97.7 %id)
BE079881 breast .i-u 193 to 780 24 to 608   tiling clone,   585/608
(96 %)
6 diff
(99.1 %id)
CV419255 breast .i-u 220 to 862 5 to 658       654/668
(97 %)
6 diff
(99.2 %id)
AA668268   .i-u 587 to 962 370 to 1       370/370
(100 %)
6 diff
(98.4 %id)
AV752156 Pituitary .i-u 598 to 1210 1 to 613       613/824
(74 %)
17 diff
(98.0 %id)
AA167173   .i-u 602 to 962 361 to 1   tiling clone,   361/361
(100 %)
0 diff
(100 %id)
AL120564 amygdala .i-u 865 to 1426 1 to 562   tiling clone,   562/562
(100 %)
2 diff
(99.7 %id)
AW996762 breast_normal .j-u 1 to 422 421 to 1   tiling clone, Submitted on the opposite strand 421/421
(100 %)
3 diff
(99.3 %id)
BU753584 placenta .j-u 119 to 776 657 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 656/668
(98 %)
0 diff
(100 %id)
N40854 placenta .j-u 121 to 540 1 to 435   fully sequenced,   435/435
(100 %)
24 diff
(94.5 %id)
H87554 placenta .j-u 122 to 545 1 to 431   fully sequenced,   431/431
(100 %)
8 diff
(98.2 %id)
BX096150 placenta .j-u 124 to 699 1 to 574   tiling clone,   574/577
(99 %)
2 diff
(99.7 %id)
AV688532 hepatocellular carcinoma .j-u 219 to 582 1 to 364       364/373
(97 %)
2 diff
(99.5 %id)
AI298037 carcinoid, lung .j-u 270 to 708 438 to 2       437/439
(99 %)
0 diff
(100 %id)
AW007410 adenocarcinoma, Pancreas .j-u 281 to 769 493 to 7   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 487/493
(98 %)
0 diff
(100 %id)
AI806617 pooled .j-u 282 to 753 478 to 10       469/478
(98 %)
0 diff
(100 %id)
H87447 placenta .j-u 515 to 701 185 to 1   fully sequenced,   185/185
(100 %)
3 diff
(98.4 %id)
N30202 placenta .j-u 515 to 763 247 to 1   fully sequenced,   247/247
(100 %)
0 diff
(100 %id)
AA737670 germinal center B cell .j-u 649 to 769 123 to 3   tiling clone,   121/123
(98 %)
0 diff
(100 %id)
AA837163 germinal center B cell .j-u 649 to 769 123 to 3       121/123
(98 %)
0 diff
(100 %id)
AA960964 pooled .j-u 651 to 762 112 to 1       112/112
(100 %)
0 diff
(100 %id)
CN292810 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j-u 665 to 760 1 to 96   AAA   96/96
(100 %)
0 diff
(100 %id)
M78772   .j-u 676 to 1101 1 to 428 T13A tiling clone,   428/428
(100 %)
4 diff
(99.1 %id)
AA344520 gall bladder .j-u 904 to 1175 1 to 272 L18X F21X C22S     272/272
(100 %)
2 diff
(99.3 %id)
AW956575   .j-u 905 to 1364 1 to 460 exact tiling clone,   460/461
(99 %)
1 diff
(99.8 %id)
BU073020.
matches multiple genes
insulinoma, Pancreas .k-u 1 to 559 8 to 566 exact tiling clone, also hits gene SSTR1 559/566
(98 %)
6 diff
(99.0 %id)
AW161959 brain, frontal lobe .k-u 273 to 584 6 to 317   fully sequenced,   312/317
(98 %)
6 diff
(98.2 %id)
AW162750 brain, frontal lobe .k-u 554 to 994 441 to 1   tiling clone, fully sequenced,   441/441
(100 %)
1 diff
(99.8 %id)
AI929796 brain, frontal lobe .k-u 611 to 994 384 to 1       384/384
(100 %)
5 diff
(98.7 %id)
AA654482   .k-u 660 to 992 333 to 1   tiling clone,   333/333
(100 %)
2 diff
(99.4 %id)
BM693777 eye, lens Gene MRPS31, variant not shown       fully sequenced, Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored    
BU738217 eye, lens Gene MRPS31, variant not shown       fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, this clone was ignored    
CN292211 embryonic stem cells, cell lines H1, H7, andH9 Gene MRPS31, variant not shown         This clone was ignored    
BG757894 B-cells, primary B-cells from tonsils (cell line) Gene MRPS31, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BQ717302 sympathetic trunk Gene MRPS31, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI